GentaMed
- Manufacturer
- Bimeda, Inc.
- Effective date
- 2022-04-19
- Label type
- PRESCRIPTION ANIMAL DRUG LABEL
- Version
- 13
- Source
- full-release
- Hydrated at
- 2026-06-01 02:41:23
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DESCRIPTION SECTION
DESCRIPTION: Each gram of GentaMed™ Soluble Powder contains gentamicin sulfate equivalent to 333.33 mg gentamicin base.
RESIDUE WARNING SECTION
RESIDUE WARNING: For use in swine drinking water only. Swine treated with the recommended dose of GentaMed™ Soluble Powder must not be slaughtered for food for at least ten (10) days following the last treatment.
INDICATIONS & USAGE SECTION
INDICATIONS: GentaMed™ Soluble Powder is recommended for the control and treatment of colibacillosis in weanling swine caused by strains of E. coli sensitive to gentamicin and for the control and treatment of swine dysentery associated with Brachyspira hyodysenteriae.
DOSAGE & ADMINISTRATION SECTION
DOSAGE AND ADMINISTRATION:
GentaMed Soluble Powder is available in a 360 gram jar. The 360 gram jar contains a scoop that provides approximately 18 grams of product when level full.
For Control and treatment of Colibacillosis-Administer GentaMed Soluble Powder in drinking water at the recommended level of 25 mg per gallon (1 scoop/240 gallons) for three consecutive days.
For Control and treatment of Swine Dysentery-Administer GentaMed Soluble Powder in drinking water at the recommended level of 50 mg per gallon (1 scoop/120 gallons) for three consecutive days.
The concentration of the medication should be adjusted in extremely hot or cold weather to ensure a gentamicin dosage of approximately 0.5 mg/lb/day for 3 days for colibacillosis or 1.0 mg/lb/day for 3 days for swine dysentery. A 50-lb pig will, under average conditions, consume 0.9 gallons of water per day.
For swine dysentery, if the condition recurs, the medication may be repeated. Because of the tendency for the disease to recur on a premise with a history of swine dysentery, a control program should be used following treatment.
DIRECTIONS FOR USE:
To prepare medicated water, mix GentaMed Soluble Powder and drinking water according to the following tables:
Proportioner Use:
For Control and Treatment of Colibacillosis
Add 18 g (1 scoop) GentaMed Soluble Powder to 2 gallons of water to make stock solution and dispense at the rate of one ounce per gallon of drinking water. This will result in drinking water that contains 25 mg/gallon.
For Control and Treatment of Swine Dysentery
Add 18 g (1 scoop) GentaMed Soluble Powder to 1 gallon of water to make stock solution and dispense at the rate of one ounce per gallon of drinking water. This will result in drinking water that contains 50 mg/gallon.
Bulk Preparation:
For Control and Treatment of Colibacillosis
Add 18 g (1 scoop) GentaMed Soluble Powder to 240 gallons of water.
For Control and Treatment of Swine Dysentery
Add 18 g (1 scoop) GentaMed Soluble powder to 120 gallons of water.
Medicated drinking water should not be stored or offered in rusty containers since the drug is quickly destroyed in such containers.
Medicated water should be prepared daily and be the sole source of drinking water for 3 consecutive days.
The daily water consumption figures shown below are approximations for mild temperatures and are presented as a guide only. Actual water consumption varies with environmental temperature, humidity, and diet.
Approximate Daily Water Consumption
| Weight of Pig(lb) | Gallon for 5 Pigs | Gallons for 10 Pigs |
| 25 | 3.0 | 6.0 |
| 50 | 4.5 | 9.0 |
| 75 | 6.0 | 12.0 |
| 100 | 7.5 | 15.0 |
ADVERSE REACTIONS SECTION
SIDE EFFECTS: There have been no reported side effects following the recommended use of GentaMed™ Soluble Powder in swine.
CONTRAINDICATIONS SECTION
CONTRAINDICATIONS: There are no known contraindications to this drug when used as directed.
To report suspected adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Bimeda, Inc. at 1-888-524-6332. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at
www.fda.gov/reportanimalae.
PRECAUTIONS SECTION
PRECAUTIONS: Store at controlled room temperature 20°C - 25°C (68°F - 77°F), with excursions permitted to 15°C - 30°C (59°F - 86°F).
HOW SUPPLIED SECTION
HOW SUPPLIED: GentaMed™ Soluble Powder is available in a 360 gram jar with 12 jars per shipper.
DESCRIPTION SECTION
GentaMed™ Soluble Powder
(Gentamicin Sulfate)
Contains 120 grams of Gentamicin per jar
Antibacterial
FOR ANIMAL USE ONLY - KEEP OUT OF REACH OF CHILDREN
Restricted Drug (California)-Use Only as Directed
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Approved by FDA under ANADA # 200-494
Net weight: 360 g (12.7 oz)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| GENTAMICIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3b7b3a7a-635f-32a3-0c6c-7ad028e3de91 | Product name | 2 | 20250107 |
| 43025f0d-698c-68da-cec9-ea4261a7ef7a | Product name | 2 | 20250107 |
| d3946667-8212-d1f2-67e1-5643a329bb56 | Product name | 2 | 20200403 |
| 4ce5dce5-e8a7-e4f6-0059-b527e4307477 | Product name | 2 | 20190501 |
| 48b05f5d-d2fc-45ab-76e8-3cb5bd44890d | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61133-5135-1 | GentaMed | 360 g in 1 JAR | POWDER | 360 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61133-5135 | GENTAMED (GENTAMICIN SULFATE) POWDER [BIMEDA, INC.] | 13 | 1 package rows | 20220420_da771fe5-e7dc-4eec-8827-778879811e49.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| gentamicin sulfate | ACTIVE INGREDIENT | 8X7386QRLV | 4 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | 4 |
Products#
Every source-derived product name is available through these pages.
- GentaMed
- gentamicin sulfate
- GENTAMICIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61133-5135 | 61133-5135-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| gentamicin sulfate | 8X7386QRLV | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin Sulfate | GENTAMICIN SULFATE | Hospira, Inc. | 977180b3-a222-4282-d485-4a3217674305 | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cardinal Health 107, LLC | 5113bfad-42ca-4bb8-9343-0b08c6cd03f0 | 2026-05-08 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Preferred Pharmaceuticals Inc. | 5ac8ea7a-ee89-49f5-8d30-6dbb56503d94 | 2026-05-05 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Henry Schein, Inc | 84f6eb1c-a287-489a-8c3e-aa5954cf1992 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Henry Schein, Inc. | 913a36c3-50d6-429a-a8dd-a03126d2ca08 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 3532bb39-a1a6-9d67-e063-6294a90abc0c | 2025-05-15 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 5193ed8d-44c9-46fe-924d-93aaea922cfd | 2025-05-01 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 0bef2a01-69d0-cf50-e063-6294a90a4c52 | 2025-02-03 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 84f5c763-1cd3-4d85-9afb-934db8666fbf | 2024-10-11 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals, Inc. | 4add8f7b-48f0-6b6a-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | HF Acquisition Co LLC, DBA HealthFirst | e9fbe619-2afe-f1d7-e053-2a95a90aab29 | 2024-01-27 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | a9486ae1-350b-41c5-ae0c-a4d692bb2dfd | 2024-01-15 | Adverse reactions | GENTAMICIN SULFATE |
| gentamicin sulfate | GENTAMICIN SULFATE | DIRECT RX | 51a411a0-2671-4c1c-bf25-e29b32efed0c | 2024-01-10 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Sandoz Inc | a213fb9c-08ea-4f30-a6c9-93c7a9ba5280 | 2024-01-02 | Warnings, Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 16474069-510b-0754-9d78-9bc0354f6549 | 2023-11-23 | Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Cosette Pharmaceuticals, Inc. | 9e550dc9-509e-da05-8a97-ecbd0f5dd633 | 2023-11-22 | Adverse reactions | GENTAMICIN SULFATE |
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | GENTAMICIN SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
